[Development of serum LATS activity in some cases of Basedow's disease treated with corticoids or immunodepressants].
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D002231:Carbimazole / Q000627:therapeutic use; D002699:Chlorambucil / Q000494:pharmacology / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D003864:Depression, Chemical; D005128:Eye Diseases / Q000188:drug therapy; D005260:Female; D006111:Graves Disease / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone; D006980:Hyperthyroidism / Q000188:drug therapy; D008135:Long-Acting Thyroid Stimulator / Q000097:blood*; D008297:Male; D051379:Mice; D008875:Middle Aged; D011241:Prednisone / Q000494:pharmacology / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy; D013997:Time Factors; D014284:Triiodothyronine / Q000494:pharmacology / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D014284:Triiodothyronine; D002699:Chlorambucil; D002231:Carbimazole; D008135:Long-Acting Thyroid Stimulator; D001379:Azathioprine; D003348:Cortisone; D011241:Prednisone; D006854:Hydrocortisone
Evolution de l'activité sérique LATS sur quelques Basedow traités par corticoïdes ou immuno-dépresseurs.